NEWS RELEASE: Lubrizol launches Tecothane Soft AR-65A TPU for interventional medical devices
Very soft, 100% TPU combines 65A performance with chemical resistance, thin-wall processability, and manufacturing versatility
CLEVELAND, OH — Lubrizol announces the launch of Tecothane Soft AR-65 TPU, a medical-grade thermoplastic polyurethane that gives engineers a new option at the flexible edge of interventional-device design. The material combines very soft 65A performance with chemical resistance, thin-wall processability, and the manufacturing versatility of a 100% TPU.
Designed for neurovascular, peripheral vascular, and cardiac delivery catheters, Tecothane Soft AR-65A supports design opportunities that benefit from both material softness and processing versatility. Its properties can help enable softer distal sections, slimmer profiles, and complex device architectures while supporting the processing and integration required for reliable manufacturing.
Performance Benefits
- Very Soft. 100% TPU: Reaches 65A Shore hardness without blending or additives.
- Chemical Resistance Beyond Softness: Demonstrates excellent chemical resistance to support catheter performance during use.
- Thin-Wall Processing Capability: Provides a material option for low-profile, highly flexible components where softness and manufacturability matter.
- Designed to Integrate: Supports established joining methods, including reflow, solvent, laser, and RF welding, for use in complex, multisegmented constructions.
- A Platform for Customization: Compatible with hydrophilic coatings and can be customized to address broader device requirements.
“Tecothane Soft AR-65A reflects Lubrizol’s commitment to helping device developers solve challenges across the full device architecture,” said Jennifer Green, Sr. Global Technical Business Development Manager. “Our medical TPU portfolio, including Tecothane, Tecoflex, and Pellethane medical-grade TPU, offers designers material options for the performance, manufacturability, and design requirements needed for next-generation medical devices.”
Tecothane Soft TPU debuts at MD&M Midwest 2026 in Minneapolis, Minnesota, October 28–29, where Lubrizol will showcase its latest medical solutions and innovations. Speak directly with Lubrizol technical experts to explore the material’s potential for interventional-device design by visiting booth 2712.
To learn more about Tecothane Soft TPU, contact your Lubrizol representative or visit https://www.lubrizol.com/solutions/products/tecothane.
About the Lubrizol Corporation
Lubrizol, a Berkshire Hathaway company, is a science-based company whose specialty chemistry delivers sustainable solutions to advance mobility, improve well-being and enhance modern life. Every day, the innovators of Lubrizol strive to create extraordinary value for customers at the intersection of science, market needs and business success, driving discovery and creating breakthrough solutions that enhance life and make the world work better. Founded in 1928, Lubrizol has global reach and local presence, with more than 100 manufacturing facilities, sales and technical offices and more than 7,000 employees around the world. For more information, visit www.Lubrizol.com.
The opinions expressed in this news release are the author’s only and do not necessarily reflect those of Medical Design & Outsourcing or its employees.
